Cerevel: See Their Revenue, Competitors, Traffic, and Reviews (August 2025)

Review (August 2025)

15.95M

Estimated Revenue

10k

Website Visitors

4/5

Trustpilot Score

What do we know about Cerevel Therapeutics?

Estimated Revenue (2020)

$15.95M

Total Employees

110 Founded

2018

Industry

Pharmaceuticals

Location

Cambridge, United States

About

Cerevel Therapeutics: Cerevel

Social Links

What is Cerevel Therapeutics's Revenue?

Cerevel Therapeutics's estimated revenue for 2024 is $15.95M.

What does Cerevel Therapeutics do?

Cerevel Therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (CNS). The company has a portfolio of experimental neuroscience therapies, which include three clinical-stage compounds and several pre-clinical compounds designed to target a broad range of CNS disorders, including Parkinson's, Alzheimer's, epilepsy, schizophrenia and addiction. Headquartered in the Greater Boston area, Cerevel was formed in 2018 through a partnership between Bain Capital and Pfizer.

Hbomax

Say hello to hbo max, the streaming platform that bundles all of hbo together with even more of your favorite movies and tv series, plus new max originals.... More